Objective-To investigate the hypothesis that release of adipokines by epicardial adipose tissue (EAT) is dysregulated in obesity and/or coronary artery disease (CAD), along with the previously documented expansion of the tissue, and that these molecules induce pathophysiological changes in human monocytes and coronary artery endothelial cells. Methods and Results-In white nondiabetic patients with CAD (nϭ62) or without CAD (control group) (nϭ32), subdivided by body mass index of Յ27 and Ͼ27, 13 cytokines were identified by protein array analysis as EAT products. Interleukin 6, interleukin 8, monocyte chemoattractant protein 1, plasminogen activator inhibitor 1, growth-related oncogene-␣, and macrophage migration inhibitory factor were the most abundant. Adiponectin release was suppressed in patients with obesity and CAD, and regulated on activation T-cell and secreted (RANTES) was induced in patients with CAD. EAT-conditioned media induced migration of monocytic tryptophan hydroxylase 1 (THP-1) cells, an effect exacerbated in those with CAD. Moreover, conditioned media from patients with CAD and body mass index of Ͼ27 increased the adhesion of THP-1 cells to human coronary artery endothelial cells by 15.1% (Pϭ0.002) and expression of intercellular adhesion molecule 1 by 2.8-fold (Pϭ0.002). This effect was reversed by recombinant adiponectin. 
pidemiological data have established a close association between obesity and increased cardiovascular morbidity and mortality. 1 Adipokines, the secretory products of adipose tissue, represent a novel and causative link between obesity and atherosclerosis. Adiponectin, leptin, interleukin (IL) 6, tumor necrosis factor ␣, and plasminogen activator inhibitor (PAI) 1 all affect vessel wall homeostasis. 2 The adipose organ is dispersed, and its effects on the vasculature depend on its abundance and location. Thus, although the large subcutaneous adipose tissue (SAT) depots mostly determine circulating levels of adipokines, perivascular depots, such as the epicardial adipose tissue (EAT) around the coronary arteries, are likely to have a direct impact on atherosclerosis as the result of anatomical proximity. Indeed, periadventitial adiponectin or proinflammatory cytokines can affect the atherosclerotic process in vivo, 3, 4 after reaching the intima either by diffusion across the vessel wall or via the vasa vasorum. 5, 6 EAT has recently been investigated, 7 and imaging studies 8, 9 have described its size and distribution in large populations. Its metabolic and secretory functions are thought to be similar to visceral adipose tissue, with which it shares common embryonic origin. 10 Both proinflammatory/proatherogenic and antiinflammatory/atheroprotective molecules are expressed in EAT at levels that usually differ from the subcutaneous depot. 7, [11] [12] [13] They are associated with the presence and extent of coronary artery disease (CAD), [13] [14] [15] whereas the significance of obesity remains unclear. However, data on the expression of these molecules, mostly at the RNA level and less at the protein level, do not prove causality. For EAT to be significant, it has to actively release molecules at levels that can induce relevant biological effects.
Therefore, the aims of this study were as follows: (1) to characterize adipokine release by EAT from white nondiabetic patients and (2) to investigate whether these molecules induce pathophysiological changes in human monocytes and/or coronary artery endothelial cells (HCAECs), dependent on obesity and CAD.
Methods

Study Population
Patients undergoing elective cardiac surgery (nϭ94), diagnosed as having CAD (nϭ62) or not (nϭ32, control group undergoing valve replacement) were recruited and divided into those with body mass index (BMI; calculated as weight in kilograms divided by height in meters squared) of Յ27 or Ͼ27. This cutoff was chosen because it corresponds to a threshold for abnormal glucose metabolism and increased mortality. 16, 17 CAD was defined angiographically as the presence of 1 or more stenoses of greater than 50% of the luminal diameter for the left main stem artery and greater than 75% for the rest of the coronary arteries. Patients of nonwhite origin, diagnosed as having diabetes mellitus, systemic inflammatory/terminal illnesses, and HIV infection or lipodystrophy; or those who underwent recent surgery or were treated with corticosteroids or nonsteroidal antiinflammatory drugs, other than low-dose aspirin, were excluded. All patients gave informed written consent for the study, which was approved by the local ethics committee.
Body weight, height, and waist circumference at the midpoint between the lowest rib and the upper iliac crest were measured (to the nearest 0.1 kg/0.1 cm) in light clothing without shoes. Blood pressure was measured with a random 0 sphygmomanometer. Demographic data, medical history, family history of CAD, current medications, and smoking habits were recorded.
Blood and Adipose Tissue Sampling
Fasting venous blood samples (20 mL) were collected preoperatively, and serum/plasma was stored at Ϫ80°C. Fasting glucose, lipid, highsensitivity (hs)-C-reactive protein, and insulin levels were assessed; and the Homeostasis Model Assessment Index-Insulin Resistance (IR) was calculated as described in the supplemental Material (available online at http://atvb.ahajournals.org).
SAT, 0.5 to 2.0 g, was excised from the site of sternotomy incision; and EAT, 0.4 to 1.0 g, was excised close to the course of the right coronary artery, approximately 45 minutes after the anesthetic and before the initiation of cardiopulmonary bypass.
Adipose Tissue Organ Culture
After removal of visible vessels and fibrous tissue, SAT/EAT samples were finely minced and 2ϫ50 mg were incubated in serum-free medium, 0.5 mL, enriched with BSA, 1 g/L (Cellgro Complete) for 24 hours at 37°C and 5% CO 2 . At the end of the incubation, tissue was snap frozen in liquid nitrogen and stored at Ϫ80°C along with the culture supernatant. In a subset of patients (nϭ18), the tissue was used for DNA extraction (as a marker of cell numbers) (DNeasy Blood & Tissue kit; Qiagen). Tissue responsiveness to hormones was examined with isoprenaline and was found to be comparable after 4-and 24-hour incubations. Previous studies have shown that the tissue remains viable for longer than 72 hours. 18 
Adipokine Assays
A cytokine protein array (Human Cytokine Array Panel A; R&D Systems) was used to analyze EAT-conditioned media from representative patients (nϭ19), as previously described. 12 Levels of total adiponectin, leptin, monocyte chemoattractant protein (MCP) 1, PAI-1, regulated on activation T-cell and secreted (RANTES), soluble IL-6 receptor (sIL-6R), growth-related oncogene ␣ (GRO␣), and soluble intercellular adhesion molecule (sICAM) 1 were determined in serum and EAT-conditioned ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CAD, coronary artery disease; CCB, calcium channel blocker.
*Data are given as percentage of patients unless otherwise indicated. †P values represent comparisons using a 1-way ANOVA or the Kruskal-Wallis, 2 , or Fisher exact test as appropriate. ‡Data are given as median (IQR). §Data are given as meanϮSD. ¶Defined as luminal stenosis Ͼ75%, or Ͼ50% for the left main stem artery. Left main stem disease was scored as 3-vessel disease.
media by commercial ELISAs. IL-6 in conditioned media was analyzed by normal-sensitivity ELISA (range, 3 to 300 pg/mL) and in serum by high-sensitivity ELISA (range, 0.16 to 10.00 pg/mL) (all available from R&D Systems). Adiponectin isoforms were determined in serum as previously described, with small modifications. 19 All interassay and intra-assay coefficients of variation were less than 10%.
HCAEC and Monocyte Experiments
HCAECs (TCS Cellworks; Park Leys) and tryptophan hydroxylase 1 (THP-1) cells, a human monocytic cell line (ATCC), were cultured as described in the supplemental material. HCAECs were treated with EAT-conditioned or serum-free media for 12 hours and mRNA expression of vascular cell adhesion molecule (VCAM) 1, ICAM-1, and E-selectin was assessed by quantitative RT-PCR. Unstimulated HCAECs were used to assess adipoR1/2 expression.
HCAECs were treated for 6 hours with EAT-conditioned medium from the 4 groups, and the adhesion assay was performed as previously described, with modifications. 20 The migration of THP-1 cells toward EAT-conditioned media; recombinant MCP-1, 20 ng/mL (positive control) 21 ; or serum-free media was assessed in a 48-well Boyden chamber, as previously described, 22 after 1 hour of incubation. Details are included in the supplemental material.
Gene Expression
Total RNA was extracted from paired EAT/SAT samples, 100 mg, and HCAECs (RNeasy Lipid Tissue Mini Kit; Qiagen) and 0.5 g of RNA was reverse transcribed (Taqman Reverse Transcription Re- Adiponectin and RANTES release from EAT. A, Adiponectin release by EAT from the control/BMI of Յ27 group (nϭ21), the control/BMI of Ͼ27 group (nϭ36), the CAD/BMI of Յ27 group (nϭ17), and the CAD/BMI of Ͼ27 group (nϭ11). B, RANTES release by EAT from the control/BMI of Յ27 group (nϭ9), the control/BMI of Ͼ27 group (nϭ13), the CAD/BMI of Յ27 group (nϭ8), and the CAD/BMI of Ͼ27 group (nϭ8). Box plots represent median, interquartile range, range, and outliers. agents; Roche). Transcripts encoding various genes were measured by quantitative RT-PCR (ABI Prism 7900HT Sequence Detection System; Applied Biosystems) with commercial primers (CD68 and CD11b; Qiagen) or primers designed by Primer Express 2.0 (adipoR1/2, VCAM-1, ICAM-1, and E-selectin; sequences are included in the supplemental material). Data are expressed as fold or percentage change compared with the reference category and were analyzed with the 2 Ϫ⌬⌬ C T method. 23 
Statistical Analyses
Data were analyzed using SPSS, version 15 
Results
Patient Characteristics
The demographic and clinical characteristics of the study participants are shown in Table 1 . As expected in a population undergoing cardiac surgery, the prevalence of other comorbidities and cardiovascular risk factors was high. For clinical reasons, use of aspirin and statins was significantly more common in patients with CAD. Circulating metabolic and inflammatory markers are included in the supplemental table.
Circulating Adipokines
Circulating adipokine levels are shown in the supplemental table. Leptin concentration was higher in patients with BMI Ͼ27, both with and without CAD. Adiponectin concentration was lower in the CAD/BMI Ͼ27 subgroup compared with the control/BMI of Յ27 subgroup; each of the adiponectin isoforms followed similar to the total adiponectin trends (supplemental Figure I ). Significant and previously reported correlations were noted between adipokines and indexes of obesity, insulin sensitivity, inflammation, and lipid levels (supplemental Material).
Release of Adipokines by EAT
Thirteen cytokines were detected by cytokine protein array in EAT-conditioned media from 19 patients, representative of the 4 groups (ie, IL-6, IL-8, MCP-1, PAI-1), monocyte migration inhibitory factor (MIF), GRO␣, IL-1 receptor antagonist, sICAM-1, IL-16, IL-13, RANTES, complement 5a, and granulocyte colony-stimulating factor, Ͼ10% of the positive control (Figure 1 ). In addition, IL-17E, IL-23, IL-27, chemokine C-C ligand 1, chemokine C-X-C ligands 10 and 11, and soluble triggering receptor expressed on myeloid cells 1 were detected only in some patients (nϭ1 to 3). Six molecules (IL-6, IL-8, MCP-1, PAI-1, MIF, and GRO␣) were abundant in EAT-conditioned media from all patients (Ͼ50% of positive control) ( Figure 1 ). The same 13 cytokines were detected in SAT cultures (nϭ3, data not shown).
Of the cytokines previously detected, release of IL-6, MCP-1, PAI-1, RANTES, GRO␣, and sICAM-1, together with sIL-6R, leptin, and adiponectin, was confirmed by ELISAs. Compared with SAT, EAT secreted significantly higher concentrations of all adipokines, apart from RANTES (supplemental Figure II) . Significantly higher concentrations of DNA per gram of EAT suggested more cells in this depot compared with SAT (supplemental Figure III) . This finding may account, at least in part, for the greater adipokine release. sICAM-1 levels were close to the limit of detection of the ELISA and, therefore, not further reported.
EAT-Derived Adipokines in Obesity and CAD
The protein array data suggested that epicardial release of RANTES, sICAM-1, IL-13, IL-16, and IL-1 receptor antagonist is increased in patients with CAD and/or BMI of Ͼ27 ( Figure 1) ; however, this method is at best semiquantitative. Therefore, we investigated adipokine release in a larger number of patients with ELISAs.
Release of adiponectin by EAT was suppressed both in obesity and CAD, with the highest concentrations seen in control subjects with BMI of Յ27 (Figure 2A) . CAD was also associated with increased RANTES release from EAT, independently of BMI ( Figure 2B ). Subcutaneous release of adiponectin and RANTES showed similar trends. Furthermore, epicardial release of adiponectin and RANTES correlated significantly with systemic levels (rϭ0. 26 Epicardial leptin release was not associated with obesity (or CAD), in contrast to subcutaneous release, which was higher in patients with BMI of Ͼ27. Epicardial IL-6, MCP-1, PAI-1, sIL-6R, and GRO␣ levels also did not differ between the groups.
The more prevalent use of aspirin and statins in patients with CAD and the higher number of females among control patients were accounted for in multiple regression analysis (Table 2 ). Epicardial adiponectin is independently associated with both obesity and CAD. Furthermore, CAD acts as an independent predictor of RANTES and IL-6 release, whereas statins appear to suppress the release of proinflammatory cytokines (ie, RANTES, IL-6, and MCP-1). Aspirin therapy, which is discontinued 1 week before surgery, was not associated with cytokine release.
Given that infiltrating macrophages account significantly for cytokine secretions from adipose tissue, we evaluated mRNA expression of 2 macrophage markers (CD68 and CD11b) in whole EAT samples. No significant differences were noted among the 4 study groups. However, CD68 levels correlated positively with MCP-1 secretion from EAT (rϭ0.48, Pϭ0.03), and CD11b levels correlated negatively with adiponectin secretion (rϭϪ0.56, Pϭ0.005).
In summary, obesity and CAD may differentially regulate the balance between proinflammatory and antiinflammatory EAT products. Obesity is primarily associated with changes in adiponectin, whereas CAD is associated with changes in both adiponectin and RANTES.
Epicardial Adipokines Induce Adhesion of THP-1 Cells to HCAECs
Having established secretion of both proinflammatory and antiinflammatory mediators from EAT, their effects on cellular populations implicated in atherosclerosis were then investigated. Treatment of HCAECs with EAT-conditioned media from patients with CAD and BMI of Ͼ27 increased the adhesion of THP-1 cells by 15.1% compared with baseline (Pϭ0.002) ( Figure 3A ) and the expression of ICAM-1 in HCAECs by 2.8-fold. No changes were seen in VCAM-1 and E-selectin expression ( Figure 3B ). EAT-conditioned media from the CAD/ BMI of Յ27 group did not promote adhesion significantly and did not increase expression of ICAM-1 ( Figure 3A and B) . EAT-conditioned media from control patients also did not induce adhesion ( Figure 3A) ; the expression of adhesion molecules was not assessed as the result of shortage of media.
HCAECs express AdipoR1 and AdipoR2 mRNA (at 40% and 19%, respectively, of the hepatic Huh7 cells, major adiponectin target). AdipoR1 protein was also present in HCAECs ( Figure 3C ). Supplementation of EAT-conditioned media from CAD/BMI Ͼ27 patients, with recombinant globular adiponectin, 1500 ng/mL (levels achievable in EAT culture media), reduced adhesion to baseline ( Figure 3A) .
Epicardial Adipokines Induce Migration of THP-1 Cells, an Effect Exacerbated in CAD
In atherosclerosis, the adhesion of monocytes is followed by migration across the endothelial layer. EAT-conditioned media from the 4 patient groups induced migration of THP-1 cells across a polycarbonate membrane. Media from the control groups induced migration by 63.4% (BMI Յ27) and 83.3% (BMI Ͼ27) of that induced by MCP-1, 20 ng/mL; media from the CAD groups induced migration by 112% (BMI Յ27) and 117% (BMI Ͼ27) respectively, 20 ng/mL (Figure 4) . EAT-conditioned media from patients with CAD induced significantly more migration compared with controls (114.8Ϯ89.8% versus 74.0Ϯ59.4%; Pϭ0.008). Migration was not associated with MCP-1 levels in EAT-conditioned media, but correlated inversely with adiponectin levels (rϭϪ0.25, Pϭ0.02).
Discussion
We investigated the release of adipokines by EAT and their potential to interact with cells implicated in atherosclerosis in 4 distinct patient groups defined by obesity and CAD. First, we confirm that EAT, in addition to secreting adiponectin, acts as a rich source of multiple proinflammatory mediators. Second, both obesity and CAD are differentially associated with alterations in the prevailing balance between proinflammatory and antiinflammatory signals derived from EAT and, thus, with its net biological effect. Last, epicardial adipokines from patients with CAD and/or increased BMI induce inflammatory changes in monocytes and HCAECs.
EAT Is a Rich Source of Adipokines
By using a cytokine protein array, we identified, for the first time to our knowledge, a number of proinflammatory medi- ators (ie, GRO␣, sICAM-1, MIF, and IL-8) as abundant products of EAT, both in the presence and in the absence of CAD. In addition, IL-6, sIL-6R, and MCP-1 were also secreted by this tissue, as previously described in individuals undergoing coronary artery bypass graft surgery. 7 Many of these molecules participate in several stages of the atherosclerotic process: chemotaxis, foam cell formation, smooth muscle cell proliferation and migration, and plaque destabilization. 24 Therefore, it is plausible that EAT, as a source of these mediators, directly surrounding the coronary arteries, can play a role in cardiovascular disease.
Obesity per se was associated with low adiponectin release from EAT. The same was noted for CAD, in agreement with previous reports. 14, 15, 25 Also, CAD, independently of obesity, was associated with increased RANTES release by EAT, a chemokine that contributes to atherosclerotic plaque formation. 26 Inflammatory pathways, mediated by nuclear factor-B and Jun N-terminal kinase, are upregulated in EAT in the presence of CAD 27 ; whether the same occurs in obesity and whether these mediators regulate adipokine release remain to be investigated.
Our data suggest that statins suppress cytokine release by EAT. A previous study, 7 which found no associations between medication and proinflammatory EAT secretions, included only patients with CAD. Despite medication, obesity and CAD alter adiponectin, RANTES, and IL-6 levels and contribute to a proinflammatory environment in the vicinity of the coronary arteries.
Epicardial Adipokines Interact With HCAECs and Monocytes
Characterization of the secretions from EAT enables the investigation of their putative role(s) in atherosclerosis. In animal models, periadventitial production of adiponectin and proinflammatory cytokines affected endothelial function in vivo. 3, 4 Given that analogous studies are not feasible in humans, we evaluated the effects of EAT-conditioned media on HCAECs in vitro. Coronary artery cells, as opposed to other endothelial cells, were used for these experiments because their specific anatomical origin modulates endothelial responses. 28 Treatment with EATconditioned media from patients with CAD and BMI of Ͼ27 induced expression of ICAM-1 in HCAECs, leading to enhanced adhesion of monocytic cells to the surface of these cells. Supplementation of the conditioned media with recombinant adiponectin inhibited monocyte adhesion, suggesting that diminished secretion of this adipokine may account, at least in part, for these findings. Indeed, adiponectin has previously been shown to inhibit cytokine-induced expression of adhesion molecules and monocyte adhesion, via inhibition of nuclear factor-B signaling. 29 Furthermore, we showed that EAT-conditioned media have chemotactic effects and induce migration of monocytic THP-1 cells, effects that are exacerbated in the presence of CAD. MCP-1, the prototype monocyte chemoattractant, and other chemokines also implicated in monocyte trafficking (GRO␣, MIF, and RANTES) 30, 31 are abundant in EAT-conditioned media and may, in concert, mediate this effect. However, the magnitude of migratory response was associated with the levels of adiponectin, rather than the proinflammatory load. Thus, the increased migration noted in those with CAD may owe more to suppressed antiinflammatory signals. Overall, adiponectin appears to be an important modulator of the effects of EAT in the initiation of atherosclerotic processes and may represent an important future therapeutic target.
Limitations of the Study
Anatomical and ethical restrictions make EAT accessible only in patients undergoing cardiac surgery. This limits our ability to perform longitudinal or comparative studies of EAT with other abdominal visceral adipose tissue depots from the same patient. CAD is an absolute indication for aspirin and statin treatment. These agents have antiinflammatory effects on adipose tissue 32, 33 and were less frequently used by control patients; their effects could only be accounted for statistically. Finally, this study focused on a white nondiabetic cohort to avoid the confounding effects of ethnicity and diabetes and its accompanying pharmacotherapies on adipose tissue; therefore, the results need to be further ascertained in other ethnic groups and in patients with type 2 diabetes.
Conclusions
In conclusion, we identified several novel inflammatory mediators (eg, GRO␣, IL-8, MIF, and sICAM-1) as part of the EAT secretome. In a well-characterized human cohort, which included patients without CAD and across the adiposity spectrum, it is apparent that the secretory profile of EAT is altered in those with obesity and/or CAD. Importantly, this study highlights the direct pathophysiological significance of EAT-generated adipo- kines in atherosclerosis. In obesity and CAD, epicardial adipokines can induce cell surface expression of adhesion molecules, enhance adhesion of monocytes to endothelial cells, and facilitate migration of adherent monocytes. Animal studies suggest that EAT products might also modulate atherosclerosis via regulation of endothelial nitric oxide synthesis and vascular smooth muscle cell function. 34 Other emerging data 35 demonstrate effects of adipokines on cardiomyocytes. Thus, the interactions between EAT-derived adipokines and neighboring cells and organs may represent future therapeutic targets for cardiovascular disease.
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